Norofert (Romania) Performance
| NRF Stock | 3.70 0.08 2.12% |
Norofert has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.14, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Norofert's returns are expected to increase less than the market. However, during the bear market, the loss of holding Norofert is expected to be smaller as well. Norofert SA right now secures a risk of 1.92%. Please verify Norofert SA skewness, day typical price, and the relationship between the downside variance and daily balance of power , to decide if Norofert SA will be following its current price movements.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Norofert SA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Norofert is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Norofert |
Norofert Relative Risk vs. Return Landscape
If you would invest 361.00 in Norofert SA on August 31, 2024 and sell it today you would earn a total of 9.00 from holding Norofert SA or generate 2.49% return on investment over 90 days. Norofert SA is generating 0.0558% of daily returns assuming 1.9158% volatility of returns over the 90 days investment horizon. Simply put, 17% of all stocks have less volatile historical return distribution than Norofert, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Norofert Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Norofert's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Norofert SA, and traders can use it to determine the average amount a Norofert's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0291
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | NRF | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.92 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Norofert is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Norofert by adding it to a well-diversified portfolio.
Things to note about Norofert SA performance evaluation
Checking the ongoing alerts about Norofert for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Norofert SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Norofert's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Norofert's stock performance include:- Analyzing Norofert's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Norofert's stock is overvalued or undervalued compared to its peers.
- Examining Norofert's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Norofert's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Norofert's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Norofert's stock. These opinions can provide insight into Norofert's potential for growth and whether the stock is currently undervalued or overvalued.